FDA Approves <br />Neurotech Company, for Testing Brain Chip, in Humans.<br />FDA Approves <br />Neurotech Company, for Testing Brain Chip, in Humans.<br />Activist Post reports that brain-computer interface, or BCI, represents the latest frontier of artificial intelligence and biology.<br />While this technology is still early in development,<br />a growing number of companies are already <br />looking at its commercial applications.<br />On July 28, one of those companies, New York startup Synchron, received FDA approval to test its brain device in human patients.<br />Stentrode, Synchron’s implantable device, is small enough to be implanted via a blood vessel at the base of the neck.<br />The device is then maneuvered <br />toward a vessel in the brain.<br />Stentrode works <br />by communicating <br />through a tiny wire <br />with a second implant <br />in the chest.<br />A transmitter then sends signals to an external computer near the patient.<br />We have worked together to pave <br />a pathway forward, towards <br />the first commercial approval <br />for a permanently implanted BCI <br />for the treatment of paralysis, Thomas Oxley, Synchron CEO, via Activist Post.<br />We have worked together to pave <br />a pathway forward, towards <br />the first commercial approval <br />for a permanently implanted BCI <br />for the treatment of paralysis, Thomas Oxley, Synchron CEO, via Activist Post.<br />The company plans to enroll six patients <br />in its U.S. trial later this year.<br />According to Oxley, the U.S. study will take <br />a closer look at safety issues, including <br />physical risks and cybersecurity.<br />Activitst Post reports an FDA-approved product could be on the market in as soon as 3 to 5 years
